Zilico hand-held device for rapid cervical cancer detection

Ellery B, Mundy L, Hiller JE
Record ID 32011000611
Authors' recomendations: The early evidence suggests that the EIS probe could effectively distinguish between tissue types and assist as a more objective means to identify (pre)cancerous changes to the cervix. The technology may also assist in improved selection of sites for biopsy, especially where colposcopy and EIS results are in agreement. Colposcopy is a subjective technique which relies to a great extent on operator skill. The Zilico device is objective as it identifies regions of abnormal impedance, therefore the operator knows that an abnormal area exists and sampling should proceed until that area has been identified. Although this technology may increase costs initially, this should be offset by improvements in the performance of colposcopy. HealthPACT have recommended that this technology be assessed for further information in 24-months time when the results if clinical trials are likely to have been published.
Project Status: Completed
Year Published: 2010
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Australia
MeSH Terms
  • Dielectric Spectroscopy
  • Uterine Cervical Neoplasms
Organisation Name: Adelaide Health Technology Assessment
Contact Address: School of Public Health, Mail Drop 545, University of Adelaide, Adelaide SA 5005, AUSTRALIA, Tel: +61 8 8313 4617
Contact Name: ahta@adelaide.edu.au
Contact Email: ahta@adelaide.edu.au
Copyright: Adelaide Health Technology Assessment (AHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.